Experts say that China began to buy global PPE stocks from Australia, Europe and the USA around the same period.
China’s anti-lockdown protests spread to Wuhan in major challenge to Xi Jinping
Chinese protestors toppled Covid-quarantine bars in Wuhan, as anti-lockdown demonstrations spread throughout the country. This was the largest challenge to Xi Jinping’s rule since he took power a decade back.
China began stockpiling PPE before the Covid epidemic
Experts say that China began to buy global PPE stocks from Australia, Europe and the USA around the same period.
Feedback PLC (AIM:FDBK) Bleepa wins two NHS Contract Awards
Award of twelve-month contracts with two NHS Trusts, for an aggregate value of £200,000
Microsaic Systems (AIM:MSYS) Board Appointment and Strategic Update
Microsaic (AIM: MSYS) is pleased to announce the appointment of Robert Moore as an Independent Non-executive Director of the Company, with immediate effect.
TPI provided its latest research note on DeepVerge plc (DVRG.L) and Microsaic Systems plc (MSYS.L).
News updates from both DeepVerge and Microsaic have been released this morning. Modern Water, a division of DeepVerge, announced a total of £2.2m of new orders for its enhanced monitoring
Microsaic Systems (MSYS.L) Update on DeepVerge Collaboration
Microsaic (AIM: MSYS), is pleased to note the update by DeepVerge plc (AIM: DVRG) (“DeepVerge”) provided today regarding their orders for pathogen monitoring equipment for shipment this year to partners
Microsaic Systems (MSYS.L) Heads of Terms signed with manufacturer in China
Production to commence in 2021 and on track for China medical device licence in 2022
The first UK NHS body to make its own protective masks in the north-east England
Filtering Face Piece 3 masks, (FFP3) were used extensively in hospitals during the pandemic.
Tern (TERN.L) Wyld Offers The Best Chance Of A Re-Rate
Tern invests in UK start-ups in the multibillion IoT and Healthcare spaces and nurtures and grows them for sale primarily in US markets at US valuations.
Evelo Biosciences (NASDAQ: EVLO) Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
CAMBRIDGE, Mass. and LONDON, June 22, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO) a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologic therapies,